Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

BACKGROUND: Among breast cancers, the triple-negative breast cancer (TNBC) subtype has the worst prognosis with no approved targeted therapies and only standard chemotherapy as the backbone of systemic therapy. Unique metabolic changes in cancer progression provide innovative therapeutic opportuniti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Metab
Autors principals: Lanning, Nathan J., Castle, Joshua P., Singh, Simar J., Leon, Andre N., Tovar, Elizabeth A., Sanghera, Amandeep, MacKeigan, Jeffrey P., Filipp, Fabian V., Graveel, Carrie R.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568171/
https://ncbi.nlm.nih.gov/pubmed/28852500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-017-0168-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars